Paul Tudor Jones Catalent, Inc. Transaction History

Tudor Investment Corp Et Al

$15.5 Billion
Q1 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Catalent, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 130,129 shares of CTLT stock, worth $7.31 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

130,129

Holding current value

$7.31 Million

% of portfolio

0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $5.54 Million - $7.78 Million	130,129 New	130,129 $7.35 Million
Q3 2023 Nov 15, 2023	BUY	$44.2 - $50.2 $286,990 - $325,948	6,493 New	6,493 $295,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $396,102 - $775,170	9,570 New	9,570 $431,000
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $2.05 Million - $2.69 Million	23,553 New	23,553 $2.53 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $3.96 Million - $5.24 Million	-42,078 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $5.03 Million - $5.85 Million	42,078 New	42,078 $5.39 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $1.71 Million - $2.22 Million	-15,619 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $1.57 Million - $1.81 Million	15,619 New	15,619 $1.69 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $4.29 Million - $5.29 Million	-42,216 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $2.57 Million - $3.15 Million	29,883 Added 242.3%	42,216 $4.39 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $1.46 Million - $1.86 Million	-20,088 Reduced 61.96%	12,333 $1.06 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $1.56 Million - $2.56 Million	32,421 New	32,421 $2.38 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $443,022 - $533,208	-9,414 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $446,694 - $546,482	9,414 New	9,414 $449,000
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $416,666 - $575,330	-10,613 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $27,035 - $39,791	-906 Reduced 7.87%	10,613 $431,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $1.68 Million - $2.6 Million	-56,196 Reduced 82.99%	11,519 $359,000
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $655,480 - $744,195	16,338 Added 31.8%	67,715 $3.08 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $1.25 Million - $1.37 Million	32,312 Added 169.48%	51,377 $2.15 Million
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $751,161 - $903,490	19,065 New	19,065 $783,000
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $1.74 Million - $2.01 Million	-46,672 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $1.58 Million - $1.94 Million	46,672	46,672 $1.86 Million

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

172M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.1B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account